New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A4760

Introduced
10/11/22  
Refer
10/11/22  
Refer
3/23/23  

Caption

Requires DEP and Drinking Water Quality Institute to perform study concerning regulation and treatment of perfluoroalkyl and polyfluoroalkyl substances.

Impact

If enacted, the bill signifies a proactive approach to managing PFAS contamination in drinking water, which has been a critical public health issue. The DEP's study is expected to evaluate effective treatment technologies that could be employed to remove PFAS from both drinking water and wastewater. This could lead to the establishment of more stringent drinking water standards, which could ultimately enhance public health protections across New Jersey.

Summary

Assembly Bill A4760 requires the New Jersey Department of Environmental Protection (DEP) to conduct a comprehensive study on the regulation and treatment of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in drinking water. The bill envisions a detailed assessment focusing on the feasibility of establishing a maximum contaminant level or other standards for PFAS as a class, instead of addressing each individual substance separately. This aligns with growing concerns about the widespread presence of PFAS in the environment due to historical usage in consumer products.

Contention

However, there are notable points of contention surrounding the regulation of PFAS. Some stakeholders may argue about the implementation costs associated with any potential new standards and technology adaptations required for compliance. Furthermore, the complexity of PFAS as a class of chemicals, with over 12,000 variations, raises questions about how broadly or specifically regulations should be applied. Advocates for stringent regulations emphasize the importance of addressing these substances comprehensively to safeguard public health and prevent future contamination.

Notable_details

The bill mandates that the DEP submit its findings within 24 months of enactment. This timeline reflects a sense of urgency in addressing PFAS pollution, which has been linked to various health risks. The importance of community engagement and public advisories related to these findings will be crucial, as the study outcomes may prompt further legislative actions related to environmental health standards.

Companion Bills

NJ S3176

Same As Requires DEP and Drinking Water Quality Institute to perform study concerning regulation and treatment of perfluoroalkyl and polyfluoroalkyl substances.

Previously Filed As

NJ A3113

Requires DEP to perform certain assessments concerning regulation of perfluoroalkyl and polyfluoroalkyl substances.

NJ A3112

Requires public water systems and landlords to provide certain notice of elevated perfluoroalkyl or polyfluoroalkyl substances levels in drinking water; requires DEP to establish educational program.

NJ A3125

Limits perfluoroalkyl and polyfluoroalkyl substances in menstrual products.

NJ S3835

Requires DEP to perform certain assessments concerning regulation of perfluoroalkyl and polyfluoroalkyl substances.

NJ SB1313

Drinking water: perfluoroalkyl and polyfluoroalkyl substances.

NJ A2033

"Protecting Against Forever Chemicals Act"; establishes requirements, prohibitions, and programs for regulation of perfluoroalkyl and polyfluoroalkyl substances (PFAS).

NJ A1328

Requires producer of certain firefighting equipment containing perfluoroalkyl and polyfluoroalkyl substances to provide written notice to purchaser; prohibits sale, manufacture, and distribution of certain firefighting equipment containing intentionally added perfluoroalkyl and polyfluoroalkyl substances.

NJ LD493

An Act to Expand Testing for Perfluoroalkyl and Polyfluoroalkyl Substances to Private Drinking Water Wells

NJ AB1603

An act to add Article 19 (commencing with Section 13200) to Chapter 2 of Division 7 of the Food and Agricultural Code, relating to pesticides.

NJ S1230

Perfluoroalkyl and Polyfluoroalkyl Substances

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.